Unknown

Dataset Information

0

Targeting metabolism to treat multiple sclerosis.

ABSTRACT:

SUBMITTER: Bhargava P 

PROVIDER: S-EPMC7996022 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Targeting metabolism to treat multiple sclerosis.

Bhargava Pavan P  

Neural regeneration research 20210301 3

Similar Datasets

Unknown Targeting the gut to treat multiple sclerosis.
| S-EPMC8245171 | biostudies-literature
Unknown Can We Treat Secondary Progressive Multiple Sclerosis Now?
| S-EPMC6472227 | biostudies-literature
Unknown Cladribine to Treat Relapsing Forms of Multiple Sclerosis.
| S-EPMC5722776 | biostudies-literature
Unknown Targeting the ribosome to treat multiple myeloma.
| S-EPMC10905045 | biostudies-literature
Unknown Number Needed to Treat in Multiple Sclerosis Clinical Trials.
| S-EPMC5447556 | biostudies-literature
Unknown Fc multimers effectively treat murine models of multiple sclerosis
| S-EPMC10451071 | biostudies-literature
Unknown Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients.
| S-EPMC8842147 | biostudies-literature
Unknown Manipulating Macrophage/Microglia Polarization to Treat Glioblastoma or Multiple Sclerosis.
| S-EPMC8877500 | biostudies-literature
Unknown Atacicept: targeting B cells in multiple sclerosis.
| S-EPMC3002656 | biostudies-literature
Unknown Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis.
| S-EPMC5497536 | biostudies-literature